BRAF-V600E DEGRADATION AS A THERAPEUTIC STRATEGY IN BRAF-V600E MUTANT GLIOMAS

被引：0
|
作者：
Zhao, Guisheng [1 ]
Muldoon, Daniel [1 ]
Mo, Xiulei [2 ]
Tang, Cong [2 ]
Fu, Haian [2 ]
Gustafson, W. Clay [3 ]
Weiss, William A. [3 ]
Nicolaides, Theodore [1 ]
机构：
[1] New York Univ Langone Hlth, Dept Pediat, New York, NY USA
[2] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[3] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
THER-17
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [41] Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma
    Schreck, Karisa C.
    Strowd, Roy E.
    Nabors, Louis B.
    Ellingson, Benjamin M.
    Chang, Michael
    Tan, Sze K.
    Abdullaev, Zied
    Turakulov, Rust
    Aldape, Kenneth
    Danda, Neeraja
    Desideri, Serena
    Fisher, Joy
    Iacoboni, Michaella
    Surakus, Trisha
    Rudek, Michelle A.
    Bettegowda, Chetan
    Grossman, Stuart A.
    Ye, Xiaobu
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2048 - 2056
  • [42] REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY
    Zapotocky, Michal
    Ryall, Scott
    Fukuoka, Kohei
    Stucklin, Ana Guerreiro
    Bennett, Julie
    Sumerauer, David
    Pavelka, Zdenek
    Cruz, Ofelia
    Solano, Palma
    Garre, Maria Luisa
    Hauser, Peter
    Frappaz, Didier
    Hansford, Jordan
    Amayiri, Nisreen
    Morse, Helena
    Sabel, Magnus
    Bechensteen, Anne Grete
    Su, Jack
    Karajannis, Matthias
    Finlay, Jonathan
    Eisenstat, David
    Canete, Adela
    Toledano, Helen
    Dahiya, Sonika
    Leary, Sarah
    Nicolaides, Theodore
    Finch, Elisabeth
    Mueller, Sabine
    Levy, Jean Mulcahy
    Ellison, David
    Lassaletta, Alvaro
    Larouche, Valerie
    Ramaswamy, Vijay
    Dirks, Peter
    McKeown, Tara
    Bartels, Ute
    Bouffet, Eric
    Hawkins, Cynthia
    Tabori, Uri
    NEURO-ONCOLOGY, 2018, 20 : 117 - 117
  • [43] BRAF-V600E AND P53 MUTATION AS A POTENTIAL PROGNOSTIC MARKERS OF REMISSION DURATION
    Kryachok, I.
    Skrypets, T.
    Novosad, O.
    Khranovska, N.
    Svergun, N.
    Grabovoy, O.
    Antoniuk, S.
    HAEMATOLOGICA, 2015, 100 : 764 - 765
  • [44] Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
    Shahabi, Vafa
    Whitney, Gena
    Hamid, Omid
    Schmidt, Henrik
    Chasalow, Scott D.
    Alaparthy, Suresh
    Jackson, Jeffrey R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (05) : 733 - 737
  • [45] Braf-V600e immunohistochemical analyses in a series of 15, Caucasian patients affected by lentigo maligna
    Dika, Emi
    Lambertini, Martina
    Fanti, Pier Alessandro
    Scarfi, Federica
    Corti, Barbara
    Altimari, Annalisa
    Ceccarelli, Claudio
    Pesci, Silvia
    Evangelista, Valeria
    Patrizi, Annalisa
    ACTA HISTOCHEMICA, 2019, 121 (03) : 380 - 381
  • [46] Clinical Characteristics that Affect the Success Rate of BRAF-V600E Oncomine Dx Target Test
    Sato, Y.
    Hara, S.
    Shima, Y.
    Shimada, Y.
    Osaki, M.
    Matsunashi, A.
    Hirabayashi, R.
    Nagata, K.
    Nakagawa, A.
    Tachikawa, R.
    Tomii, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S454 - S454
  • [47] Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments
    Ros, J.
    Matito, J.
    Villacampa, G.
    Comas, R.
    Garcia, A.
    Martini, G.
    Baraibar, I.
    Saoudi, N.
    Salva, F.
    Martin, A.
    Antista, M.
    Toledo, R.
    Martinelli, E.
    Pietrantonio, F.
    Boccaccino, A.
    Cremolini, C.
    Dientsmann, R.
    Tabernero, J.
    Vivancos, A.
    Elez, E.
    ANNALS OF ONCOLOGY, 2023, 34 (06) : 543 - 552
  • [48] Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
    Vafa Shahabi
    Gena Whitney
    Omid Hamid
    Henrik Schmidt
    Scott D. Chasalow
    Suresh Alaparthy
    Jeffrey R. Jackson
    Cancer Immunology, Immunotherapy, 2012, 61 : 733 - 737
  • [49] Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation
    Tiacci, Enrico
    Schiavoni, Gianluca
    Forconi, Francesco
    Santi, Alessia
    Trentin, Livio
    Ambrosetti, Achille
    Cecchini, Debora
    Sozzi, Elisa
    di Celle, Paola Francia
    Di Bello, Cristiana
    Pulsoni, Alessandro
    Foa, Robin
    Inghirami, Giorgio
    Falini, Brunangelo
    BLOOD, 2012, 119 (01) : 192 - 195
  • [50] Comparative molecular analyses of BRAF-V600E mutant tumors: Colorectal cancers (CRC) vs. melanomas.
    Christiansen, Shelly Ann
    Feldman, Rebecca
    Atkins, Michael B.
    El-Deiry, Wafik S.
    Vanderwalde, Ari M.
    Pishvaian, Michael J.
    Hwang, Jimmy J.
    Flaherty, Lawrence E.
    Denlinger, Crystal Shereen
    Reddy, Sandeep K.
    Marshall, John
    Salem, Mohamed E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345